The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Tygacil

50 milligram(s) Pdr/Conc/Soln for Infus

Pfizer Europe MA EEIGEU/1/06/336/01

Main Information

Trade NameTygacil
Active SubstancesTigecycline
Strength50 milligram(s)
Dosage FormPdr/Conc/Soln for Infus
Licence HolderPfizer Europe MA EEIG
Licence NumberEU/1/06/336/01

Group Information

ATC CodeJ01AA Tetracyclines
J01AA12 tigecycline

Status

Authorised/WithdrawnAuthorised
Licence Issued24/04/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back